Insider Transactions in Q2 2024 at Hims & Hers Health, Inc. (HIMS)
Insider Transaction List (Q2 2024)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 03
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
125,199
-16.21%
|
$2,503,980
$20.56 P/Share
|
|
Jun 03
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
125,199
+12.64%
|
$751,194
$6.22 P/Share
|
|
May 31
2024
|
Michael Chi Chief Commercial Officer |
SELL
Open market or private sale
|
Direct |
396,181
-27.78%
|
$7,527,439
$19.9 P/Share
|
|
May 31
2024
|
Michael Chi Chief Commercial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
396,181
+21.05%
|
$1,980,905
$5.92 P/Share
|
|
May 30
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
129,667
-24.39%
|
$2,593,340
$20.82 P/Share
|
|
May 30
2024
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
129,667
+31.16%
|
$648,335
$5.01 P/Share
|
|
May 28
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,502
-1.57%
|
$42,534
$17.33 P/Share
|
|
May 21
2024
|
Christopher D Payne Director |
BUY
Open market or private purchase
|
Indirect |
110,000
+50.0%
|
$1,870,000
$17.74 P/Share
|
|
May 21
2024
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
38,131
-6.95%
|
$648,227
$17.93 P/Share
|
|
May 21
2024
|
Oluyemi Okupe Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
28,084
+12.89%
|
$140,420
$5.01 P/Share
|
|
May 20
2024
|
Oluyemi Okupe Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,900
-4.09%
|
$138,000
$20.01 P/Share
|
|
May 20
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
4,915
-2.99%
|
$98,300
$20.01 P/Share
|
|
May 20
2024
|
Soleil Boughton Chief Legal Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,915
+2.91%
|
$24,575
$5.01 P/Share
|
|
May 17
2024
|
Irene Becklund PAO |
SELL
Open market or private sale
|
Direct |
943
-100.0%
|
$13,202
$14.5 P/Share
|
|
May 17
2024
|
Irene Becklund PAO |
BUY
Exercise of conversion of derivative security
|
Direct |
943
+50.0%
|
$8,487
$9.41 P/Share
|
|
May 13
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,503
-1.55%
|
$30,036
$12.33 P/Share
|
|
May 13
2024
|
Christiane Pendarvis Director |
SELL
Open market or private sale
|
Direct |
4,000
-26.3%
|
$48,000
$12.33 P/Share
|
|
May 09
2024
|
Patrick Harrison Carroll Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-5.44%
|
$130,000
$13.0 P/Share
|
|
May 03
2024
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
11,750
-0.54%
|
$129,250
$11.93 P/Share
|
|
May 03
2024
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,750
+2.09%
|
$0
$0.4 P/Share
|
|
May 02
2024
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
11,750
-1.07%
|
$141,000
$12.08 P/Share
|
|
May 02
2024
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,750
+2.09%
|
$0
$0.4 P/Share
|
|
May 01
2024
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
11,750
-1.07%
|
$141,000
$12.61 P/Share
|
|
May 01
2024
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,750
+2.09%
|
$0
$0.4 P/Share
|
|
May 01
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
144,444
-9.93%
|
$1,733,328
$12.69 P/Share
|
|
May 01
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
188,888
-75.0%
|
$2,266,656
$12.54 P/Share
|
|
May 01
2024
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
188,888
+50.0%
|
$377,776
$2.43 P/Share
|
|
Apr 29
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,503
-1.52%
|
$30,036
$12.56 P/Share
|
|
Apr 15
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,503
-1.5%
|
$32,539
$13.95 P/Share
|
|
Apr 08
2024
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
11,751
-1.07%
|
$164,514
$14.74 P/Share
|
|
Apr 08
2024
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,751
+2.09%
|
$0
$0.4 P/Share
|
|
Apr 05
2024
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
11,751
-1.07%
|
$164,514
$14.59 P/Share
|
|
Apr 05
2024
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,751
+2.09%
|
$0
$0.4 P/Share
|
|
Apr 04
2024
|
Melissa Baird Chief Operating Officer |
SELL
Open market or private sale
|
Direct |
11,751
-1.07%
|
$164,514
$14.89 P/Share
|
|
Apr 04
2024
|
Melissa Baird Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
11,751
+2.09%
|
$0
$0.4 P/Share
|
|
Apr 04
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Indirect |
144,444
-4.56%
|
$2,166,660
$15.05 P/Share
|
|
Apr 04
2024
|
Andrew Dudum Chief Executive Officer |
SELL
Open market or private sale
|
Direct |
188,888
-62.35%
|
$2,833,320
$15.3 P/Share
|
|
Apr 04
2024
|
Andrew Dudum Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
188,888
+50.0%
|
$377,776
$2.43 P/Share
|
|
Apr 01
2024
|
Soleil Boughton Chief Legal Officer |
SELL
Open market or private sale
|
Direct |
2,503
-1.48%
|
$37,545
$15.65 P/Share
|